Cadrenal Therapeutics Stock Forecast

Sell candidate since Jul 06, 2026 Loss -10.42%

The Cadrenal Therapeutics, Inc. stock price fell by -2.90% on the last day (Thursday, 9th Jul 2026) from $3.10 to $3.01. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 5.42% from a day low at $2.95 to a day high of $3.11. The price has fallen in 7 of the last 10 days but is still up by 1.01% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -14 thousand shares and in total, 48 thousand shares were bought and sold for approximately $145.76 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -41.12% during the next 3 months and, with a 90% probability hold a price between $1.42 and $2.55 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CVKD Signals & Forecast

There are mixed signals in the stock today. The Cadrenal Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.25 and $3.90. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Thursday, June 25, 2026, and so far it has risen 5.24%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Cadrenal Therapeutics, Inc. stock

Cadrenal Therapeutics, Inc. finds support from accumulated volume at $2.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.160 between high and low, or 5.42%. For the last week the stock has had daily average volatility of 11.25%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CVKD) For The Upcoming Trading Day Of Friday 10th

For the upcoming trading day on Friday, 10th we expect Cadrenal Therapeutics, Inc. to open at $3.02, and during the day (based on 14 day Average True Range), to move between $2.79 and $3.23, which gives a possible trading interval of +/-$0.441 (+/-15.82%) up or down from last closing price. If Cadrenal Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 15.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.98 (1.00%) than the resistance at $3.10 (2.99%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cadrenal Therapeutics, Inc. stock A Buy?

Cadrenal Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.172 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 10, 2026 - $3.02 ( 0.443%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk